{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:40:45Z","timestamp":1786120845536,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NSFC82073345"],"award-info":[{"award-number":["NSFC82073345"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of Shandong Province Innovation and Development Joint Fund","award":["ZR202209010002"],"award-info":[{"award-number":["ZR202209010002"]}]},{"name":"the Taishan Scholars Program, and the Jinan Clinical Medicine Science and Technology Innovation Plan","award":["202019060"],"award-info":[{"award-number":["202019060"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"DOI":"10.1186\/s40164-026-00789-x","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:04:58Z","timestamp":1780423498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Radiotherapy synergizes with CD24 blockade to initiate macrophage-driven systemic antitumor immunity in non\u2013small cell lung cancer"],"prefix":"10.1186","volume":"15","author":[{"given":"Gongjun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deli","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanghu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"11\u201312","key":"789_CR1","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00335-018-9777-0","volume":"29","author":"KJ McKelvey","year":"2018","unstructured":"McKelvey KJ, Hudson AL, Back M, Eade T, Diakos CI. Radiation, inflammation and the immune response in cancer. Mamm Genome. 2018;29(11\u201312):843\u201365.","journal-title":"Mamm Genome"},{"issue":"2","key":"789_CR2","doi-asserted-by":"publisher","first-page":"e005862","DOI":"10.1136\/jitc-2022-005862","volume":"11","author":"Y Liu","year":"2023","unstructured":"Liu Y, Pagacz J, Wolfgeher DJ, Bromerg KD, Gorman JV, Kron SJ. Senescent cancer cell vaccines induce cytotoxic T cell responses targeting primary tumors and disseminated tumor cells. J Immunother Cancer. 2023;11(2):e005862.","journal-title":"J Immunother Cancer"},{"issue":"7","key":"789_CR3","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/cac2.12576","volume":"44","author":"Y Wu","year":"2024","unstructured":"Wu Y, Yi M, Niu M, Zhou B, Mei Q, Wu K. Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors. Cancer Commun (Lond). 2024;44(7):739\u201360.","journal-title":"Cancer Commun (Lond)"},{"issue":"5","key":"789_CR4","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.ccell.2025.02.024","volume":"43","author":"YP Zhang","year":"2025","unstructured":"Zhang YP, Guo ZQ, Cai XT, Rong ZX, Fang Y, Chen JQ, et al. PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy. Cancer Cell. 2025;43(5):856\u2013e8749.","journal-title":"Cancer Cell"},{"issue":"3","key":"789_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ccell.2025.02.010","volume":"43","author":"J Chen","year":"2025","unstructured":"Chen J, Levy A, Tian AL, Huang X, Cai G, Fidelle M, et al. Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients. Cancer Cell. 2025;43(3):361\u2013e37910.","journal-title":"Cancer Cell"},{"issue":"8","key":"789_CR6","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41571-025-01029-7","volume":"22","author":"LB Tang","year":"2025","unstructured":"Tang LB, Peng YL, Chen J, Li JT, Zheng MM, Wu L, et al. Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer. Nat Rev Clin Oncol. 2025;22(8):546\u201365.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"789_CR7","doi-asserted-by":"publisher","first-page":"e02037","DOI":"10.1002\/advs.202502037","volume":"13","author":"Z Wang","year":"2025","unstructured":"Wang Z, Fang Y, Huang X, Ma G, Mao Q, Lu X, et al. Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical Trials. Adv Sci (Weinh). 2025;13(3):e02037.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"789_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s40164-025-00720-w","volume":"14","author":"J Zhong","year":"2025","unstructured":"Zhong J, Jie G, Qin H, Li H, Chen N, Aerxiding P, et al. Immunotherapy for small cell lung cancer: current challenges and prospects. Exp Hematol Oncol. 2025;14(1):130.","journal-title":"Exp Hematol Oncol"},{"issue":"4","key":"789_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nri3191","volume":"12","author":"NP Restifo","year":"2012","unstructured":"Restifo NP, Dudley ME, Rosenberg SA. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol. 2012;12(4):269\u201381.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"789_CR10","doi-asserted-by":"publisher","first-page":"e003887","DOI":"10.1136\/jitc-2021-003887","volume":"10","author":"J Guo","year":"2022","unstructured":"Guo J, Luo N, Ai G, Yang W, Zhu J, Li C, et al. Eradicating tumor in a recurrent cervical cancer patient with autologous tumor-infiltrating lymphocytes and a modified lymphodepleting regimen. J Immunother Cancer. 2022;10(2):e003887.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"789_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-025-01734-x","volume":"18","author":"L Huang","year":"2025","unstructured":"Huang L, Zhu H, Shi Y. Immune checkpoint inhibitors for the treatment of solid tumors and lymphoma in the past 26 years (2000\u20132025). J Hematol Oncol. 2025;18(1):107.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"789_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12951-023-01791-9","volume":"21","author":"GJ Gu","year":"2023","unstructured":"Gu GJ, Chung H, Park JY, Yoo R, Im HJ, Choi H, et al. Mannosylated-serum albumin nanoparticle imaging to monitor tumor-associated macrophages under anti-PD1 treatment. J Nanobiotechnol. 2023;21(1):31.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"789_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40164-023-00372-8","volume":"12","author":"W Ma","year":"2023","unstructured":"Ma W, Xue R, Zhu Z, Farrukh H, Song W, Li T, et al. Increasing cure rates of solid tumors by immune checkpoint inhibitors. Exp Hematol Oncol. 2023;12(1):10.","journal-title":"Exp Hematol Oncol"},{"issue":"11","key":"789_CR14","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s43018-022-00456-0","volume":"3","author":"Y Nishiga","year":"2022","unstructured":"Nishiga Y, Drainas AP, Baron M, Bhattacharya D, Barkal AA, Ahrari Y, et al. Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect. Nat Cancer. 2022;3(11):1351\u201366.","journal-title":"Nat Cancer"},{"issue":"6","key":"789_CR15","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1158\/0008-5472.CAN-25-2616","volume":"86","author":"L Kong","year":"2026","unstructured":"Kong L, Zhou M, Yuan W, Wang Y, Liu X, Wang J, et al. Radiation-Enhanced CD24 Membrane Trafficking via GPI Anchoring Mediates Anti-Tumor Immune Evasion. Cancer Res. 2026;86(6):1480\u201395.","journal-title":"Cancer Res"},{"issue":"1","key":"789_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40164-023-00469-0","volume":"13","author":"M Cao","year":"2024","unstructured":"Cao M, Wang Z, Lan W, Xiang B, Liao W, Zhou J, et al. The roles of tissue resident macrophages in health and cancer. Exp Hematol Oncol. 2024;13(1):3.","journal-title":"Exp Hematol Oncol"},{"issue":"7769","key":"789_CR17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","volume":"572","author":"AA Barkal","year":"2019","unstructured":"Barkal AA, Brewer RE, Markovic M, Kowarsky M, Barkal SA, Zaro BW, et al. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature. 2019;572(7769):392\u20136.","journal-title":"Nature"},{"issue":"23","key":"789_CR18","doi-asserted-by":"publisher","first-page":"e71443","DOI":"10.1002\/cam4.71443","volume":"14","author":"M Yu","year":"2025","unstructured":"Yu M, Ni M, Xu F, Fang C, Li J, Wu X, et al. Overexpressed CD24 and CD47 Indicate a Worse Prognosis in Cervical Cancer. Cancer Med. 2025;14(23):e71443.","journal-title":"Cancer Med"},{"issue":"1","key":"789_CR19","doi-asserted-by":"publisher","first-page":"10039","DOI":"10.1038\/s41467-025-65945-z","volume":"16","author":"SY Wu","year":"2025","unstructured":"Wu SY, Zhu YY, Sun JL, Wang CY, Wang YL, Nie YY, et al. Targeting tumor-intrinsic BCL9 reverses immunotherapy resistance by eliciting macrophage-mediated phagocytosis and antigen presentation. Nat Commun. 2025;16(1):10039.","journal-title":"Nat Commun"},{"issue":"D1","key":"789_CR20","doi-asserted-by":"publisher","first-page":"D18","DOI":"10.1093\/nar\/gkaa1022","volume":"49","author":"Database Resources of the National Genomics Data Center","year":"2021","unstructured":"Database Resources of the National Genomics Data Center. China National Center for Bioinformation in 2021. Nucleic Acids Res. 2021;49(D1):D18\u201328.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"789_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.gpb.2017.01.001","volume":"15","author":"Y Wang","year":"2017","unstructured":"Wang Y, Song F, Zhu J, Zhang S, Yang Y, Chen T, et al. GSA: Genome Sequence Archive\u2009<\u2009sup\/>. Genomics Proteom Bioinf. 2017;15(1):14\u20138.","journal-title":"Genomics Proteom Bioinf"},{"key":"789_CR22","doi-asserted-by":"publisher","first-page":"786864","DOI":"10.3389\/fmolb.2022.786864","volume":"9","author":"X Zhao","year":"2022","unstructured":"Zhao X, Li J, Zheng L, Yang Q, Chen X, Chen X, et al. Immune Response on Optimal Timing and Fractionation Dose for Hypofractionated Radiotherapy in Non-Small-Cell Lung Cancer. Front Mol Biosci. 2022;9:786864.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"789_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12967-023-04029-2","volume":"21","author":"P Zhao","year":"2023","unstructured":"Zhao P, Zhen H, Zhao H, Huang Y, Cao B. Identification of hub genes and potential molecular mechanisms related to radiotherapy sensitivity in rectal cancer based on multiple datasets. J Transl Med. 2023;21(1):176.","journal-title":"J Transl Med"},{"issue":"3","key":"789_CR24","doi-asserted-by":"publisher","first-page":"e003762","DOI":"10.1136\/jitc-2021-003762","volume":"10","author":"YN Yoon","year":"2022","unstructured":"Yoon YN, Lee E, Kwon YJ, Gim JA, Kim TJ, Kim JS. PI3K\u03b4\/\u03b3 inhibitor BR101801 extrinsically potentiates effector CD8\u2009+\u2009T cell-dependent antitumor immunity and abscopal effect after local irradiation. J Immunother Cancer. 2022;10(3):e003762.","journal-title":"J Immunother Cancer"},{"key":"789_CR25","doi-asserted-by":"publisher","first-page":"690188","DOI":"10.3389\/fonc.2021.690188","volume":"11","author":"JZ Lai","year":"2021","unstructured":"Lai JZ, Zhu YY, Liu Y, Zhou LL, Hu L, Chen L, et al. Abscopal Effects of Local Radiotherapy Are Dependent on Tumor Immunogenicity. Front Oncol. 2021;11:690188.","journal-title":"Front Oncol"},{"issue":"1","key":"789_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40364-024-00628-3","volume":"12","author":"X Wang","year":"2024","unstructured":"Wang X, Zhang H, XinZhang, Liu Y. Abscopal effect: from a rare phenomenon to a new frontier in cancer therapy. Biomark Res. 2024;12(1):98.","journal-title":"Biomark Res"},{"key":"789_CR27","doi-asserted-by":"publisher","first-page":"217935","DOI":"10.1016\/j.canlet.2025.217935","volume":"631","author":"C Wang","year":"2025","unstructured":"Wang C, Han L, Zhang J, Ji Q, Guo X, Li Y, et al. Radiotherapy in combination with PD-1 and TIGIT blockade mediate antitumor abscopal effects and immune memory via CD8\u2009+\u2009T cells. Cancer Lett. 2025;631:217935.","journal-title":"Cancer Lett"},{"issue":"1","key":"789_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12943-023-01885-w","volume":"22","author":"M Yi","year":"2023","unstructured":"Yi M, Li T, Niu M, Mei Q, Zhao B, Chu Q, et al. Exploiting innate immunity for cancer immunotherapy. Mol Cancer. 2023;22(1):187.","journal-title":"Mol Cancer"},{"issue":"1","key":"789_CR29","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13045-022-01363-8","volume":"15","author":"M Yi","year":"2022","unstructured":"Yi M, Niu M, Wu Y, Ge H, Jiao D, Zhu S, et al. Combination of oral STING agonist MSA-2 and anti-TGF-\u03b2\/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors. J Hematol Oncol. 2022;15(1):142.","journal-title":"J Hematol Oncol"},{"issue":"7355","key":"789_CR30","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10138","volume":"475","author":"BZ Qian","year":"2011","unstructured":"Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011;475(7355):222\u20135.","journal-title":"Nature"},{"issue":"22","key":"789_CR31","doi-asserted-by":"publisher","first-page":"e179527","DOI":"10.1172\/JCI179527","volume":"134","author":"X Liu","year":"2024","unstructured":"Liu X, Ren Z, Tan C, N\u00fa\u00f1ez-Santana FL, Kelly ME, Yan Y, et al. Inducible CCR2\u2009+\u2009nonclassical monocytes mediate the regression of cancer metastasis. J Clin Invest. 2024;134(22):e179527.","journal-title":"J Clin Invest"},{"issue":"5","key":"789_CR32","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.7150\/thno.32648","volume":"9","author":"OM Ozpiskin","year":"2019","unstructured":"Ozpiskin OM, Zhang L, Li JJ. Immune targets in the tumor microenvironment treated by radiotherapy. Theranostics. 2019;9(5):1215\u201331.","journal-title":"Theranostics"},{"key":"789_CR33","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.3389\/fimmu.2018.03154","volume":"9","author":"LB Darragh","year":"2018","unstructured":"Darragh LB, Oweida AJ, Karam SD. Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment. Front Immunol. 2018;9:3154.","journal-title":"Front Immunol"},{"key":"789_CR34","doi-asserted-by":"publisher","first-page":"1737661","DOI":"10.3389\/fimmu.2026.1737661","volume":"17","author":"L Zhou","year":"2026","unstructured":"Zhou L, Liu Q, He Y, Tang Y, Liu S, Wang X, et al. Combining advanced radiotherapy techniques and immunotherapy: immunomodulatory mechanisms and clinical prospects. Front Immunol. 2026;17:1737661.","journal-title":"Front Immunol"},{"key":"789_CR35","doi-asserted-by":"publisher","DOI":"10.1159\/000550067","author":"RC Hsieh","year":"2025","unstructured":"Hsieh RC, Chen WP, Lee JC, Lin CH, Chang YC, Lee CW, et al. Proton radiotherapy alone versus combined with immunotherapies or tyrosine kinase inhibitors for barcelona clinic liver cancer stage B or C hepatocellular carcinoma. Liver Cancer. 2025. https:\/\/doi.org\/10.1159\/000550067.","journal-title":"Liver Cancer"},{"issue":"5","key":"789_CR36","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1182\/blood.2024027506","volume":"146","author":"N Daver","year":"2025","unstructured":"Daver N, Vyas P, Huls G, D\u00f6hner H, Maury S, Novak J, et al. The ENHANCE-3 study: venetoclax and azacitidine plus magrolimab or placebo for untreated AML unfit for intensive therapy. Blood. 2025;146(5):601\u201311.","journal-title":"Blood"},{"issue":"11","key":"789_CR37","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1158\/2767-9764.CRC-25-0332","volume":"5","author":"RW Lentz","year":"2025","unstructured":"Lentz RW, Lang J, Pitts TM, Blatchford P, Hu J, Jordan KR, et al. Phase II clinical trial and preclinical evaluation of a novel CD47 blockade combination in refractory microsatellite stable metastatic colorectal cancer. Cancer Res Commun. 2025;5(11):2039\u201352.","journal-title":"Cancer Res Commun"},{"issue":"1","key":"789_CR38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13045-022-01328-x","volume":"15","author":"W Li","year":"2022","unstructured":"Li W, Wang F, Guo R, Bian Z, Song Y. Targeting macrophages in hematological malignancies: recent advances and future directions. J Hematol Oncol. 2022;15(1):110.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"789_CR39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13045-025-01742-x","volume":"18","author":"JT Wang","year":"2025","unstructured":"Wang JT, Tseng CL, Teng HF, Kuo PH, Cheng YC, Chen YJ, et al. HCB101: a novel potent ligand-trap Fc-fusion protein targeting the CD47-SIRP\u03b1 pathway with high safety and preclinical efficacy for hematological and solid tumors. J Hematol Oncol. 2025;18(1):87.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"789_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1158\/1535-7163.MCT-25-0425","volume":"25","author":"H Zhang","year":"2025","unstructured":"Zhang H, He F, Cao L, Ni H, Li N, Liu Y, et al. A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRP\u03b1-Independent Mechanism. Mol Cancer Ther. 2025;25(1):21\u201333.","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"789_CR41","doi-asserted-by":"publisher","first-page":"e009024","DOI":"10.1136\/jitc-2024-009024","volume":"12","author":"Z Wang","year":"2024","unstructured":"Wang Z, Wang B, Feng Y, Ye J, Mao Z, Zhang T, et al. Targeting tumor-associated macrophage-derived CD74 improves efficacy of neoadjuvant chemotherapy in combination with PD-1 blockade for cervical cancer. J Immunother Cancer. 2024;12(8):e009024.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"789_CR42","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s40164-025-00696-7","volume":"14","author":"Z Qi","year":"2025","unstructured":"Qi Z, Hu S, Zhao J, Xu X, Huang A, Qin Y, et al. CD47 antibody-armed oncolytic adenovirus promotes chimeric antigen receptor macrophage phagocytosis and antitumor immunity. Exp Hematol Oncol. 2025;14(1):106.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"789_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13045-025-01678-2","volume":"18","author":"Y Wu","year":"2025","unstructured":"Wu Y, Yan Y, Guo Y, Niu M, Zhou B, Zhang J, et al. Anti-TGF-\u03b2\/PD-L1 bispecific antibody synergizes with radiotherapy to enhance antitumor immunity and mitigate radiation-induced pulmonary fibrosis. J Hematol Oncol. 2025;18(1):24.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"789_CR44","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s40164-025-00705-9","volume":"14","author":"Y Wang","year":"2025","unstructured":"Wang Y, Jiang C, Zhou H, Han R. Transforming cancer immunotherapy: integration of distinct immune-based approaches as redefined dual immunotherapy with potential third-sensitizer. Exp Hematol Oncol. 2025;14(1):114.","journal-title":"Exp Hematol Oncol"},{"issue":"13","key":"789_CR45","doi-asserted-by":"publisher","first-page":"2304991","DOI":"10.1002\/advs.202304991","volume":"11","author":"W Lu","year":"2024","unstructured":"Lu W, Kangjie S, Zixu G, Ming R, Chenlu W, Yang Y, et al. Melanoma Derived Exosomes Amplify Radiotherapy Induced Abscopal Effect via IRF7\/I-IFN Axis in Macrophages. Adv Sci (Weinh). 2024;11(13):2304991.","journal-title":"Adv Sci (Weinh)"},{"key":"789_CR46","doi-asserted-by":"publisher","first-page":"114498","DOI":"10.1016\/j.intimp.2025.114498","volume":"153","author":"F Ma","year":"2025","unstructured":"Ma F, Miao X, Lin Y, Luo X, Chen T, Ni Z, et al. Microwave ablation combined with \u03b1-PD-L1 enhances abscopal effect and promotes CTL activation and intratumoral homing by a cytokine network involving IFN-\u03b3 and CXCL9. Int Immunopharmacol. 2025;153:114498.","journal-title":"Int Immunopharmacol"},{"issue":"30","key":"789_CR47","doi-asserted-by":"publisher","first-page":"e01819","DOI":"10.1002\/advs.202501819","volume":"12","author":"L Lyu","year":"2025","unstructured":"Lyu L, Yi M, Chen J, Zhang J, Ma X, Zhang X, et al. Bispecific Antibody Targeting VEGF\/TGF-\u03b2 Synergizes with Local Radiotherapy: Turning Tumors from Cold to Inflamed and Amplifying Abscopal Effects. Adv Sci (Weinh). 2025;12(30):e01819.","journal-title":"Adv Sci (Weinh)"}],"container-title":["Experimental Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40164-026-00789-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-026-00789-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-026-00789-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:43:22Z","timestamp":1786063402000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40164-026-00789-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["789"],"URL":"https:\/\/doi.org\/10.1186\/s40164-026-00789-x","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"73"}}